Webinars

OUR WEBINARS



October 2020

A Patient’s Journey With Atopic Dermatitis

Adam Friedman

MD, FAAD


Professor and Interim Chair of Dermatology

Residency Program Director

Director of Transnational Research

Director of Supportive Oncodermatology Clinic

Department of Dermatology

George Washington School of Medicine and Health Sciences

Jason Lee-LLacer And Agnes Abedela, RN, MSN

MD


Jason Lee-LLacer is a Critical Care

Medicine Specialist in Lanham MD

Details :

TUESDAY OCT 13, 2020 at 7:00PM EDT Join us for a live webinar for a panel discussion between Adam Friedman, MD and his patient, Jason Lee-Llacer, MD and his wife Agnes Abedela, RN, as they discuss his struggle with severe atopic dermatitis. This includes the various drug and adjunctive therapies used to treat and manage his condition. This panel discussion will include Q&A. Jason Lee-Llacer, MD and Agnes Abedela, RN are ICU health care providers. His AD caused severe QOL concerns, including loss of sleep, which impacted his work and social life. Part of Dr. Lee-Llacer’s treatment included two weeks of balneotherapy at the Thermal Dermatology center in La Roche-Posay, France.

Description:

The first part of this webinar will address the pathogenesis of hyperhidrosis and its psychosocial impact on our patients as well as emerging treatment options.

The second part of the webinar will discuss the use of Ixekizumab for psoriasis and psoriatic arthritis patients with a focus on its new pediatric indication in psoriasis.


October 2020

INTERNATIONAL DERMATOLOGY EDUCATION FOUNDATION EDUCATIONAL SERIES

ife

Details :

Tuesday October 6th, 2020 from 7:00PM- 8:00PM EDT Join us for these important discussions


 


September 2020

Skin Barrier Integrity and Skin of Color: What you need to know!

Heather Woolery-Lloyd

MD, FAAD


Director, Skin of Color Division

Dr Phillip Frost Department of

Dermatology and Cutaneous Surgery

University of Miami

Miller School of Medicine

Andrew F. Alexis

MD, MPH


Director, Skin of Color Center

Chair, Department of Dermatology

Mount Sinai Morningside and

Mount Sinai West

Professor, Icahn School of Medicine

at Mount Sinai

Details :

TUESDAY SEPTEMBER 29TH, 2020 at 7:00PM EDT Please join us for our next important webinar provided by CeraVe and RBC Consultants.

This presentation will cover what you need to know about the role of the skin barrier in the skin of color patient. Although conflicting data exists, several studies have confirmed key differences in the skin barrier when comparing different ethnicities. We will discuss both the clinical and cultural significance of moisturizers in skin of color patients. We will also decode moisturizer ingredients offering insights into the specific role of common key ingredients in moisturizer formulations.


September 2020

Newborn and Infant Skincare: Update on Sensitive Skin Care and Barrier function: What you need to know!

Lawrence Schachner

MD, FAAD, FAAP


Stiefel Professor

Chairman Emeritus Dermatology

Professor of Dermatology and Pediatrics

Director of Pediatric Dermatology

University of Miami School of Medicine

Peter Lechman

MD, MBA, FAAP


Associate Chief Medical Officer for Primary Care

Medical Director, Primary Care and Pediatrics

Northwestern Medical Group

Instructor of Clinical Pediatrics at

Northwestern University Feinberg School of Medicine

Attending Physician at the

Anne and Robert H. Lurie Children’s Hospital of Chicago


This presentation will provide what you need to know about the role of newborn and infant skincare in promoting important short-term and long-term health benefits to your patients. The skin of babies is still undergoing maturation during the first days, weeks, months and early years of life.

Appropriate skin care can help this maturation in barrier function and structure, decrease skin sensitivity and potentially halt the atopic march towards systemic allergic disease. We will discuss the barrier maturation and function of babies skin, simple but effective care, as well as potential transcutaneous toxicities to avoid.



August 2020

The Role of Ceramides in Skin Barrier Integrity: What You Need to Know!

Daniela P. Antelo

MD, MSC, PhD


Adjunct Professor of Dermatology

Universidade do Estado

Rio de Janeiro, Brazil

Chief of Cosmetic Dermatology

Sector of

Hospital Universitario Pedro Ernesto

Master Degree and PhD at

Dermatology

Federal University of Rio de Janeiro

Carmen Gloria Gonzalez

MD


Pediatric Dermatologist

Fellowship in Pediatric Dermatology

Feinberg School of Medicine.

Northwestern University

Member of American Academy of Dermatology

Society in Pediatric Dermatology and

European Society of Pediatric Dermatology

Associate Editor of Practical and

Conceptual Dermatology Journal


We wanted to thank everyone for attending our most recent educational webinar, The Role of Ceramides in Skin Barrier Integrity: What You Need to Know!

Dr. Daniela P. Antelo and Dr. Carmen Gloria Gonzalez both delivered excellent talks on skin barrier anatomy and function and effectiveness of Ceramide use in dermatology.



July 2020

A Forgotten Concept: pH and Skin Barrier

Leon Kircik

MD


Professeur clinique de dermatologie

École de médecine Icahn à Mount Sinai, NY

Directeur médical

Sciences de la peau, Louisville, KY

Charles W. Lynde

MD


Directeur médical

Le Lynde Institute for Dermatology &

Recherche Lynderm Inc.

professeur agrégé

Université de Toronto, Département de médecine

Details :

August 12th, 2020 at 8:00PM EDT

In this LIVE webinar, Leon Kircik, MD, FAAD and Charles Lynde, MD, FRCPC, will be reviewing the role of skin surface pH in skin barrier function as well as the challenges in balancing pH in atopic dermatitis and acne patients.

They will also be providing clinical insights into the role of skin pH in AD and acne patients as well as clinical data on the importance of moisturizers and cleansers in skin barrier function.


download (2)

Watch our Webinar with Dr. Charles W. Lynde and Dr. Leon Kircik

Click on the Youtube logo to subscribe to our channel for our upcoming Webinars.


July 2020

INTERNATIONAL DERMATOLOGY EDUCATION FOUNDATION EDUCATIONAL SERIES

ife

Details :

Thursday Jul 30th, 2020 from 8:00PM- 9:00PM EDT

- Amidst the use of personal protection equipment (PPE) during COVID 19 pandemic, we are discovering the indirect impact of the virus on our skin.

- During this session, Dr. Leon Kircik will discuss the relevant cutaneous findings and the disruption of barrier function caused with the extensive use of masks, hand sanitizers, and other PPE . We will emphasize the importance of barrier restoration with unique ceramide formulation skincare as well as the importance of maintaining natural skin pH.

- In addition, Dr. Linda Stein Gold will present on how to progress your topical patients to the next step with an oral treatment with data for moderate to severe scalp psoriasis.

-Dr Doris Day will review systemic and local effects of stress on the hair follicle and the benefits of proactive interventions.


 


July 2020

Comment naviguer dans le paysage changeant de la dermatologie et des relations de l'industrie après la pandémie

ife

Objectifs :

Mercredi le 29 Juillet, 2020 from 8:00PM- 9:00PM EDT

- Dans ce webinaire interactif en direct, le Dr Marc Bourcier partagera son point de vue sur la façon dont l’ère post COVIDE-19 aura un impact sur l’interaction de la communauté dermatologique avec l’industrie. Un groupe de dirigeants clés de l’industrie discutera de la façon dont l’industrie s’adapte à la situation pendant la pandémie de Covide-19 afin de répondre aux besoins de la communauté dermatologique au Québec. En outre, un leader d’opinion clé, le Dr Charles Lynde, partagera une perspective plus poussée du restant du Canada et le Dr Leon Kircik, partagera une perspective plus poussée du sud de la frontière. Un niveau élevé d’interactivité sera intégré à plusieurs questions de sondage et à une longue période de questions-réponses. Cette séance offrira a la communauté dermatologique et aux chefs de file de l’industrie l’occasion de mieux comprendre et d’explorer la façon de naviguer dans la « nouvelle normalité » pour les relations futures.

Altius Healthcare

Sybil Dahan

Présidente


Bausch Health

Richard Lajoie

President, Canada


Dermtek Pharma

Michel Lavoie

Président


Galderma Canada

Wendy Adams

Directeur général Canada



 


July 2020

For a Webinar discussing Antibiotics, Probiotics and Antibiotic Stewardship in the SARS-COV 2 ERA

Ellie Goldstein

MD


Stuart Johnson

MD


Ravina Kullar

PharmD


Lynne McFarland

PhD



The COVID 19 pandemic has locked down countries and stressed hospital systems worldwide. Patients who are admitted to the hospital, especially those with respiratory complications, are frequently placed on empirical antibiotics in part due to the fear of aerosolization of the virus, despite limited data showing low rates of bacterial and fungal infections. When patients get sicker, antibiotics are often empirically escalated, creating an inherent dilemma for the hospital’s Antimicrobial Stewardship program (ASP). The additional use of antibiotics, especially in ICU patients, can potentially lead to drug toxicities, allergies, prolonged hospital stays, increased bacterial resistance and associated complications such as C. difficile infection (CDI). CDI, with 428,000 cases per year with 5.2% attributable mortality, costs insurers approximately $5 billion dollars (US) in excess medical costs and is considered an urgent global threat by the WHO and CDC. Hospital ASP teams have begun to lower these rates with more restrictive antibiotic use protocols. The use of specific strains of probiotics has been shown to effectively reduce antibiotic-associated diarrhea and CDI in several randomized controlled trials (RCTs), but not all probiotic strains or mixtures are effective. An innovative strategy which involves administering specific probiotics to every inpatient who receives an antibiotic and continuing the probiotic for the duration of the antibiotic course or until discharge is proposed as an essential element of an effective CDI prevention bundle.

July 2020

How to navigate the changing landscape of dermatology and industry relationships post pandemic

Charles W. Lynde

MD


Medical Director, The Lynde Institute for

Dermatology& Lynderm Research Inc.

Associate Professor, University of Toronto,

Department of Medicine

Chair: Leon Kircik

MD


Clinical Professor of Dermatology

Icahn School of Medicine at Mount Sinai, NY

Medical Director, Skin Sciences, Louisville, KY

ife

Details

Thursday, July 23st, 2020 from 7:00PM- 8:30PM EDT

- In this live webinar, Charles W. Lynde, MD, and Leon Kircik, MD will lead the discussion on how the post-COVID-19 era will impact the future of the dermatology industry relationship. A panel of key pharmaceutical executives will discuss their perspective of the future of dermatology and how the industry is changing to adapt to serve the needs of the dermatology community. A high level of interaction will be incorporated with several polling questions and an extensive Q&A period.

This session will offer both dermatology health care professionals and industry leaders an opportunity to better understand and explore how to navigate the “new normal”.

Bausch Health

Richard Lajoie

President, Canada


Galderma Canada

Wendy Adams

General Manager


Novartis Pharmaceuticals

Andrea Marazzi

Country Pharma Organization Head


UCB Canada

Jerry Syrotuik

Scientific Head of Immunology



 

July 2020

How to navigate the changing landscape of dermatology and industry relationships post pandemic

ife

Details

Tuesday, July 21st, 2020 from 7:00PM- 8:30PM EDT

- In this live webinar, Leon Kircik, MD and Mark Lebwohl, MD will lead the discussion on how the post-COVID-19 era will impact the future of dermatology industry relationship. A panel of key pharmaceutical executives will discuss their perspective of the future of dermatology and how the industry is changing to adapt to serve the needs of the dermatology community. A high level of interaction will be incorporated with several polling questions and an extensive Q&A period. We will also have a guest ,Dr Charles Lynde from Canada who will give us Canadian viewpoint.

This session will offer both dermatology health care professionals and industry leaders an opportunity to better understand and explore how to navigate the “new normal” .

Arcutis Biotherapeutics

Frank Wantanabe

President and CEO


Bausch Health

Richard Lajoie

President, Canada


Brickell Biotech

Robert Brown

CEO


Cassiopea

Diana Harbort

CEO


Dermavant

Todd Zavodnick

CEO



Leo Pharma

Chris Posner

President and CEO


Lilly

Becki Morison

Immunology Leader USA


Novartis

Victor Bulto

President


Ortho Dermatologics

Bill Humphries

President


UCB

Rhonda Peebles

Head US Dermatology



 

July 2020

Face and Hands: Insights Into The Impact of COVID-19 on Skin Barrier Integrity

Dr. Charles W. Lynde

MD, FRCPC, DABD, FCDA


Dr. Leon Kircik

MD, FAAD


ife

Details

Wednesday, July 15th 2020 from 7:00PM- 8:00PM

- Amidst the use of personal protection equipment (PPE) during the COVID 19 pandemic, we are discovering the indirect impact of the virus on our skin.

- During this session, we will discuss the relevant cutaneous findings and the disruption of barrier function caused by the extensive use of masks, hand sanitizers, and other PPE. We will emphasize the importance of barrier restoration with unique ceramide formulation skincare as well as the importance of maintaining natural skin pH.

FREE GIFTS TO ALL ATTENDEES


download (2)

Watch our Webinar with Dr. Charles W. Lynde and Dr. Leon Kircik

Click on the Youtube logo to subscribe to our channel for our upcoming Webinars.


July 2020

Mieux Connaître l’Hidradénite Suppurée

Modératrice

Dre Isabelle Delorme

MD, FRCPC, Dermatologue


Conférencière

Dre Hélène Veillette

MD, FRCPC, Dermatologue


abb

Objectifs :

Lundi le 13 juillet 2020 de 19h00 à 20h00

- Sensibiliser les participants aux divers aspects du tableau clinique de la H.S. afin de raccourcir le délai diagnostic

- Mieux connaître la réalité vécue par les personnes atteintes de la H.S. et l’incidence de la maladie sur leur qualité de vie

- Assurer le traitement approprié grâce à une prise en charge collaborative et orienter au besoin le patient vers un dermatologue